Uncategorized
Valeant to reduce dermatological, ophthalmological prescription prices by 10% at Walgreens
Valeant Pharmaceuticals International announced today in a press release new fulfillment agreements in which Valeant will reduce prices of its branded prescription-based dermatological and ophthalmological products by 10%.The plan includes more than 8,000 Walgreens U.S. retail pharmacy locations and participating independent retailers, according to the release. Pricing applies to wholesale list prices of the products over the next 6 to 9 months.